Dimensional Fund Advisors
PSTV

Dimensional Fund Advisors’s Plus Therapeutics PSTV Stock Holding History

Dimensional Fund Advisors’s Portfolio PSTV Stock Details PSTV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-68
Closed -$27K – 3548
2021
Q4 		$27K Hold
68
– – ﹤0.01% 3521
2021
Q3 		$49K Sell
68
-114
-63% -$86.9K ﹤0.01% 3473
2021
Q2 		$175K Buy
+182
New +$164K ﹤0.01% 3359
2018
Q3 		– Sell
-2
Closed -$59K – 3434
2018
Q2 		$59K Buy
+2
New +$95.2K ﹤0.01% 3326
2014
Q3 		– Hold
0
– -$26K – 3561
2014
Q2 		– Hold
0
– – – 3481
2014
Q1 		– Hold
0
– – – 3432
2013
Q4 		– Hold
0
– – – 3308
2013
Q3 		– Hold
0
– – – 3583
2013
Q2 		– Hold
0
– – – 3585

Other funds holding PSTV

PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
OCA
Otter Creek Advisors Palm Beach Gardens, Florida $101M AUM 29.92% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Dimensional Fund Advisors's PSTV Position: Q1 2022 in Review

Dimensional Fund Advisors sold out of Plus Therapeutics (PSTV) in Q1 2022, closing a stake of 68 shares — an estimated $27K sold.

Dimensional Fund Advisors first reported a position in PSTV in Q2 2018 and held it in 4 quarters. The position peaked at $175K in Q2 2021. 14 funds tracked by Wall St. Rank hold PSTV as of Q1 2022.

  • Dimensional Fund Advisors reported no remaining Plus Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Dimensional Fund Advisors sold 68 Plus Therapeutics shares in Q1 2022, an estimated $27K.
  • Dimensional Fund Advisors first reported a position in Plus Therapeutics in Q2 2018 and held it in 4 quarters.
  • Dimensional Fund Advisors's Plus Therapeutics position peaked at $175K in Q2 2021.
  • 14 funds tracked by Wall St. Rank held Plus Therapeutics as of Q1 2022.

Based on Dimensional Fund Advisors's 13F filing for Q1 2022, filed 13 May 2022.